These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2852588)

  • 1. [Detection of carboxycathepsin (angiotensin-I-converting enzyme) inhibitors in human leukocytes].
    Eliseeva IuE; Barsukova IS; Orekhovich VN
    Dokl Akad Nauk SSSR; 1988; 302(4):992-4. PubMed ID: 2852588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peptides--inhibitors of carboxycathepsin (peptidyl-dipeptidase A) and their role in clinical medicine].
    Orekhovich VN; Eliseeva IuE; Pavlikhina LV; Krit NA; Filatova MP
    Vopr Med Khim; 1984; 30(3):51-6. PubMed ID: 6206649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endogeneous inhibitors of carboxycathepsin (angiotensin I-converting enzyme) in bovine serum].
    Kozlova NI; Pavlikhina LV; Eliseeva IuE; Orekhovich VN
    Dokl Akad Nauk SSSR; 1988; 298(6):1481-5. PubMed ID: 2837380
    [No Abstract]   [Full Text] [Related]  

  • 4. [Properties and action specificity of carboxycathepsin (peptidyl dipepsidase) from bovine kidneys].
    Eliseeva IuE; Orekhovich VN; Pavlikhina LV
    Vopr Med Khim; 1976; 22(1):81-9. PubMed ID: 193290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of amidinomercaptic acids on prolyl endopeptidase and carboxycathepsin activity (angiotensin converting enzyme)].
    Alekseenko LP; Eliseeva IuE; Pavlikhina LV; Pozdnev VF; Orekhovich VN
    Dokl Akad Nauk SSSR; 1989; 306(6):1486-9. PubMed ID: 2553370
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of carboxycathepsin (peptidyl dipeptidase) activity in human blood serum].
    Pavlikhina LV; Eliseeva IuE; Pozdnev VF; Orekhovich VN
    Vopr Med Khim; 1975; 21(1):54-60. PubMed ID: 164083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation of carboxycathepsin (peptidyl dipeptidases 3.4.15.1) from bovine kidneys].
    Eliseeva IuE; Pavlikhina LV; Orekhovich VN
    Dokl Akad Nauk SSSR; 1974 Aug; 217(4):953-6. PubMed ID: 4368167
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angiotensin converting enzyme-angiotensin II system, atherosclerosis, and angiotensin-converting enzyme inhibitors].
    Aronov DM
    Ter Arkh; 2000; 72(12):5-7. PubMed ID: 11201833
    [No Abstract]   [Full Text] [Related]  

  • 9. Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.
    Vaughan DE
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-34-7. PubMed ID: 9422850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological and pharmacological aspects of angiotensin converting enzyme.
    Fyhrquist F; Grönhagen-Riska C; Forslund T; Hortling L
    Scand J Urol Nephrol Suppl; 1984; 79():39-43. PubMed ID: 6089317
    [No Abstract]   [Full Text] [Related]  

  • 11. [The renin-angiotensin-aldosterone system, angiotensin I converting enzyme, and the ACE-inhibitors. Historical perspective and recent findings].
    Gensini GF; Lippi D; Conti AA
    Recenti Prog Med; 2002 Oct; 93(10):544-53. PubMed ID: 12405014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE, ACE inhibitors, and other JNK.
    Ryan MJ; Sigmund CD
    Circ Res; 2004 Jan; 94(1):1-3. PubMed ID: 14715529
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isolation and molecular kinetic properties of the angiotensin-converting enzyme from the human heart].
    Sakharov IIu; Danilov SM; Dukhanina EA
    Biokhimiia; 1986 Nov; 51(11):1836-42. PubMed ID: 3026499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structural and functional characteristics of angiotensin converting enzyme].
    Eliseeva IuE
    Bioorg Khim; 1998 Apr; 24(4):262-70. PubMed ID: 9612568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of angiotensin-converting enzyme in human placenta and its physiologic role in the fetal circulation.
    Yagami H; Kurauchi O; Murata Y; Okamoto T; Mizutani S; Tomoda Y
    Obstet Gynecol; 1994 Sep; 84(3):453-7. PubMed ID: 8058247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
    Husain A; Li M; Graham RM
    Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging concepts about the renin angiotensin system: present and future clinical applications.
    McLigeyo SO
    East Afr Med J; 1996 Sep; 73(9):607-10. PubMed ID: 8991244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme].
    Vernigora AN; Nikishin NN; Gengin MT
    Biokhimiia; 1995 Jan; 60(1):144-9. PubMed ID: 7696431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and properties of the angiotensin-converting enzyme from human lungs].
    Sakharov IIu; Dukhanina EA; Danilov SM
    Biokhimiia; 1986 Jun; 51(6):946-51. PubMed ID: 3015264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
    Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
    Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.